Gates aims to accelerate global access to Merck’s Covid pill
Bloomberg The Bill & Melinda Gates Foundation said millions of courses of Merck & Co’s promising pill for Covid-19 could begin to reach lower-income nations early next year as the charity kicks in as much as $120 million to widen global access to the therapy. The funds will help spur generic-drug manufacturers, some of which have indicated they could produce ...
Read More »